Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
about
Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patientsUse of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administrationWhat is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regressionRole of Oxidative Stress in Drug-Induced Kidney InjuryMyopathy caused by polymyxin E: functional disorder of the cell membraneAntibacterial agents in renal failureSafety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteriaNeurotoxic effects associated with antibiotic use: management considerationsIntravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosisThe use of intravenous colistin among children in the United States: results from a multicenter, case seriesAdvances in the pharmacotherapy of cystic fibrosis.Colistin neurotoxicity: revisited.Meta-analysis of colistin for the treatment of Acinetobacter baumannii infectionTreatment of Pseudomonas aeruginosa infection in critically ill patients.Comment: Fundamentals and Innovation in Antibiotic TrialsPolymyxins revisited.Colistin: an update on the antibiotic of the 21st century.Adverse reactions associated with systemic polymyxin therapy.The safety of polymyxin antibiotics.Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step toward Pragmatism in Benefit:risk Evaluation.Colistin and polymyxin B: a re-emergence.Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock.Management with colistin.Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.Prevalence and risk factors for acute kidney injury associated with parenteral polymyxin B use.Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity.Commentary: Management of endogenous endophthalmitis: Ophthalmologist in the role of a physician.
P2860
Q24673399-CEBBEFB1-AB2D-42A9-92C7-2284489927FFQ24682618-DDCA34BB-DEEB-4A80-A0B4-EC3843F692E5Q26999921-1BF993C4-0D86-484C-9891-39DBA3797A5EQ28074502-C3CD89BF-F243-40C3-9FF0-812553286D70Q28363617-FD12F051-72E4-422E-9E41-5D2A2A1042E6Q28365374-19565043-DA29-4A8C-9A40-EFB64BD2A6BCQ33926652-781F4C67-027A-4876-B523-A3F3396AE5F8Q35165736-9FFBA27C-FBEF-4254-9A13-9FA2829DC6FAQ35219637-5C4CF34B-BB48-48A9-9988-1872469734E8Q35563227-EDE82BC7-A5E2-4446-8442-7CD5780167CCQ35592264-A79BAED6-B9F3-4A7B-8F4E-587DA1A70FFCQ35596685-37B12A98-BE0A-4741-A137-47ECEE84E95AQ35885209-0517223D-E6BA-432E-AA79-237AD96F6C0BQ36310173-018D5CDA-0443-437B-88BB-A4DB5402B912Q36607415-AE203CFF-9A8A-4FC6-8832-8D0ECDD60479Q36798184-B9096A20-0372-43CF-8E44-6C24BE1F27C3Q37215935-1A181D11-7C53-457E-B8E0-A70B8C9116CBQ38048852-25867B67-F720-4FA2-A430-74B6D86F26D1Q38255373-D39DF770-D8FC-4282-9E99-DFEAB9DB0937Q38586123-9B56FC27-A3E8-4C86-B016-CBF6CCC03740Q38926250-CBA7A4CE-243E-4473-A5E6-D1190E6E2198Q41871984-84DA118C-962B-4B4F-BDA9-9002259316BCQ42546631-6C6CEF54-0ECC-4C11-AA4F-F29A1020E0DFQ42573290-E7A798F9-2DC1-4B27-B42A-350BF591FE65Q43097126-FEEDDA84-5D57-43ED-95FE-E9AD924B1895Q43249112-E7AA5AE3-EE81-41F1-9E84-19D18A656BEEQ46581461-4734D0C4-7CCA-4BD1-B1CC-C7EF9F2EDDC8Q55240188-2BEDDDC3-0151-4851-A35B-BD021E8D9473
P2860
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
description
1962 nî lūn-bûn
@nan
1962 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1962 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1962年の論文
@ja
1962年論文
@yue
1962年論文
@zh-hant
1962年論文
@zh-hk
1962年論文
@zh-mo
1962年論文
@zh-tw
1962年论文
@wuu
name
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@ast
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@en
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@nl
type
label
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@ast
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@en
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@nl
prefLabel
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@ast
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@en
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@nl
P1476
Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.
@en
P2093
P304
P356
10.1056/NEJM196204122661505
P407
P577
1962-04-01T00:00:00Z